Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03386682
Other study ID # Protocol CLIN PMI-002
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 23, 2018
Est. completion date April 12, 2021

Study information

Verified date April 2021
Source Symatese Aesthetics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will evaluate the safety and performance of the ESTYME® MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the breast augmentation and reconstruction.


Description:

The study will evaluate the safety and performance of the ESTYME® MATRIX Round and Anatomical Silicone Gel-Filled Breast Implants in the breast augmentation and reconstruction at 3 months, 1 year and 2 years post-procedure


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date April 12, 2021
Est. primary completion date April 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: Patient will be included if all of the following criteria are met: 1. Subject of between 18 and 65 years old 2. Candidate eligible for : a. unilateral or bilateral breast augmentation i. general breast enlargement: cosmetic purposes, providing symmetry to opposite breast in case of unilateral surgery ii. surgical correction of various congenital or acquired anomalies such as amastia, aplasia, hypomastia, hypoplasia, asymmetries, Poland's syndrome, ptosis … b. or immediate or delayed unilateral or bilateral breast reconstruction (for cancer, trauma, surgical loss of breast) 3. Patient signs PIC (Patient Informed Consent) & willing to comply with the protocol assessments and visits follow up Exclusion Criteria: Patient will not be included if any of the following conditions exists: 1. Local or systemic infection or abscess anywhere in the body 2. Existing carcinoma or pre-carcinoma of the breast without treatment or mastectomy treatment without appropriate wash out period for chemotherapy at the surgeon discretion 3. Subject with previous tissue expansion 4. Diagnosis of active cancer of any type for augmentation procedure subject 5. Pregnant subject or intending to become pregnant within three (3) months of the implant procedure 6. Subject who had nursed within three (3) months of implant surgery, or still breastfeeding 7. Tissue characteristics determined clinically inadequate or unsuitable by the surgeon (i.e. tissue damage resulting from radiation, inadequate tissue or compromised vascularity, know complication wound healing) 8. Previously implanted subject with a silicone implant or History of failure following cosmetic augmentation or subcutaneous mastectomy 9. History of autoimmune disease such as but not limited to: lupus, scleroderma … 10. Any condition or treatment for any condition which, in the opinion of the physician, may constitute an unwarranted surgical risk (e.g. anaesthesia allergy, high consumption smoking subject …) 11. Anatomic or physiologic abnormality which could result to significant post-operative complications 12. History of sensitivity of foreign materials or known allergy to any component of the ESTYME® MATRIX Silicone Gel-Filled Breast Implant 13. Subject known for alcohol abuse/history 14. Underlying disease (HIV positive Subject, HF (heart Failure), renal insufficiency, diabetes, hypertension, …) 15. Subject with implanted metal or metal devices, history of claustrophobia, or other condition that would make a MRI scan prohibitive 16. Unwilling to undergo any further surgery for revision 17. Subject with willingness that are unrealistic/unreasonable with the risks involved with the surgical procedure 18. Participating into any other clinical study or had participated into a clinical study without appropriate wash out period at the surgeon discretion 19. Subject who has sociological, cultural or geographical factors which could interfere with evaluation or completion of the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ESTYME® MATRIX Breast Implants
Breast implant surgery in breast reconstruction or breast augmentation

Locations

Country Name City State
France Centre F.X. Michelet Chu Bordeaux Bordeaux
France Chu Pasteur Nice
France Clinique BIZET Paris
France Clinique des Champs Elysées Paris
France Hopital Tenon Paris
France Institut du Sein Paris
France Clinique Charcot Sainte-Foy-lès-Lyon
France Institut Gustave Roussy Villejuif

Sponsors (2)

Lead Sponsor Collaborator
Symatese Aesthetics MedPass International

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Local complications Evaluation of the safety 3 months post-implantation.
Procedure-related adverse events/complications at 3 months post implant. Main foreseen complications: infection, haematoma, wound healing complication, fluid accumulation, early capsular contracture, rupture, extrusion.
3 months
Primary Satisfaction of the patient and the surgeon Evaluation of the performance, 3 months post-implantation
Performance endpoint will be assessed by implant procedure success at 3 months defined as follows:
satisfactory procedure duration for the surgeon
satisfactory size of the incision for the surgeon
implant correct placement (absence of visible deformation of the gel, absence of rotation for anatomical implants)
3 months
Secondary Local complications Evaluation of the safety, 1 year and two years post-implantation.
Safety endpoint: incidence of all Adverse Events (AE)/Serious Adverse Events (SAEs) @ 1 year and two years post procedure
1 year and 2 years
Secondary Satisfaction of the patient and the surgeon Performance endpoints are as follows:
global surgeon satisfaction post-procedure assessed by the usability of the device during the procedure (current implant procedure): surgeon comfort level for the insertion/implantation of the prosthesis,
global patient and surgeon satisfaction @ 1 year and 2 years post-procedure
1 year and 2 years
See also
  Status Clinical Trial Phase
Recruiting NCT03757793 - Near-infrared Spectroscopy for Monitoring Tissue Oxygenation in Breast Reconstruction
Completed NCT05491473 - Negative Pressure in PAP Donor Sites
Not yet recruiting NCT06013514 - Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
Completed NCT02169011 - Secondary Breast Reconstruction With a Flap of Skin From the Back N/A
Completed NCT01216319 - Evaluation of the Cook Biodesign Plastic Surgery Matrix N/A
Not yet recruiting NCT00973544 - Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis? N/A
Completed NCT01176786 - Reusable Versus Disposable Draping System in Breast Reconstruction Surgery N/A
Active, not recruiting NCT00748722 - Pre-Operative Imaging of Abdominal Wall Perforators Using CT Angiography N/A
Completed NCT00753922 - Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses Phase 3
Completed NCT05897463 - Nipple Neurotization
Recruiting NCT05377723 - Abdominal Scar Improvement in Microsurgical Breast Reconstruction N/A
Completed NCT04350411 - Comparison of PEAK PlasmaBlade™ to Conventional Diathermy in Abdominal Based Free Flap Breast Reconstruction N/A
Completed NCT06321549 - New Era of DIEP With Minimally Invasive Mastectomy
Withdrawn NCT03135392 - Sensation After Nipple Sparing Mastectomy and Breast Reconstruction With or Without Neurotized Free Tissue Transfer N/A
Completed NCT01256502 - The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery N/A
Active, not recruiting NCT04715802 - Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel
Active, not recruiting NCT04491591 - Implementing BREASTChoice Into Practice N/A
Recruiting NCT04661501 - BREAST ADM Trial for Alloplastic Breast Reconstruction N/A
Suspended NCT03625765 - Integrated Imaging System for In Vivo Visualization of Free Flap Perfusion Using Indocyanine Dye N/A
Withdrawn NCT00778947 - Single Centre Study to Compare Harmonic Scalpel to Conventional Diathermy in Free Tissue Transfer Breast Reconstruction N/A